The responsible use of benzodiazepines
Controversy remains about the utility and hazards of benzodiazepines, and that bewilders clinicians. This review is an update on their current state in clinical medicine.
A practical approach to the treatment of adult ADHD
The concept of attention-deficit hyperactivity disorder (ADHD) was described in children more than one hundred years ago. These children were noted to have high levels of activity and impulsivity. It was only with the publication of the DSM-II in 1968 that more descriptive criteria for attention-deficit hyperactivity disorder (ADHD) in children were formulated. More recently the DSM-5 (published in 2013), expanded the description of ADHD that are more applicable to adolescents and adults. New symptom sets were however not created for these groups. As is now well described, ADHD is a neurodevelopmental condition characterised by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The prevalence of Adult ADHD is estimated to be in the range of 1%–6%.
Attempts allowed: 2
70% pass rate